IOL Chemicals reports strong half-year profit growth

IOL Chemicals and Pharmaceuticals Limited reported a notable increase in its standalone and consolidated financial performance for the half-year ended September 30, 2025. Standalone profit for the period surged to ₹63.96 crore, up from ₹48.83 crore in the corresponding period of the previous year. Consolidated profit also increased to ₹63.90 crore, compared to ₹49.12 crore for the half-year ended September 30, 2024.

Standalone revenue from operations for the half-year reached ₹1,119.22 crore, an increase from ₹1,028.13 crore year-over-year. Consolidated revenue from operations similarly grew to ₹1,119.22 crore from ₹1,028.13 crore in the prior year. Basic and diluted earnings per equity share stood at ₹2.18 for the standalone half-year results, compared to ₹1.66 in the previous year.

The company's total comprehensive income on a standalone basis for the half-year was ₹63.71 crore, up from ₹47.48 crore in the previous year. Consolidated total comprehensive income for the same period was ₹63.65 crore, an increase from ₹47.77 crore.